Aclaris Therapeutics ACRS
NASDAQ ACRS
$5.34 +0.05 (+1.04%)
As of: Sep 30, 2026 · 3:38 PM EDT

Aclaris Therapeutics (ACRS) Current Leases (2017 - 2018)

Updated

Aclaris Therapeutics (ACRS) reported Current Leases of $601,000 for Q4 2018, up 323.2% from $142,000 a year earlier and up 1.7% from the prior quarter.

Analysis

Aclaris Therapeutics (ACRS) Current Leases (2017 - 2018) Analysis & Trends

Dating back to Q4 2017, Aclaris Therapeutics' Current Leases record includes 5 quarters.

  • By year, Current Leases came in at $142,000 in FY2017.
  • Per Business Quant data, the three quarters before Q4 2018 came in at $591,000 (Q3 2018), $552,000 (Q2 2018) and $142,000 (Q1 2018).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn -
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn -
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 274.00 Mn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -2.32 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn -
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn -
10 Aclaris Therapeutics 738.27 Mn 738.27 Mn 1.41 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 601,000.00
Sep 30, 2018 591,000.00
Jun 30, 2018 552,000.00
Mar 31, 2018 142,000.00
Dec 31, 2017 142,000.00
API Access

Aclaris Therapeutics Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=ACRS&period=max&api_key=YOUR_API_KEY